Okada S, Maeda K, Tanaka Y, Anan S, Yoshida H
Department of Dermatology, Nagasaki University School of Medicine, Japan.
J Dermatol. 1996 Apr;23(4):247-53. doi: 10.1111/j.1346-8138.1996.tb04007.x.
To elucidate the etiological role of immunoglobulin molecules on Langerhans cells (LCs) in atopic dermatitis, we conducted immuno-histochemical studies on the localization of immunoglobulin G1 (IgG1), IgG2, IgG3, IgG4, IgA and IgM on epidermal LCs from 30 patients with atopic dermatitis (AD) and five non-atopic healthy volunteers. We also investigated the types of receptors for the immunoglobulins (Fc epsilon RI, Fc epsilon RII, Fc gamma RI, Fc gamma RII, and Fc gamma RIII) on epidermal LCs in the patients. IgE positive epidermal LCs were observed in 28 of 30 AD patients, and 46.7% of the epidermal LCs were positive for IgE. Both IgG1- and IgG2-positive epidermal LCs were observed in 70% of AD patients, and 21.8% and 28.7% of the total epidermal LCs were positive for IgG1 and IgG2, respectively. IgG3- or IgG4-positive LCs were present in only small proportions of AD patients. IgA-positive LCs were observed in 8 AD patients; our study suggested that the IgA bound on LCs was secretory IgA (S-IgA). These surface immunoglobulins were observed significantly more frequently on epidermal LCs in the involved skin of AD than in clinically uninvolved skin. No IgM-positive epidermal LCs were observed in the AD patients or healthy volunteers. In non-atopic healthy controls, no immunoglobulin-binding LCs were observed. In receptors for immunoglobulins, Fc epsilon RI and Fc gamma RII were exclusively expressed on nearly all epidermal LCs from all AD patients and all non-atopic controls. These results suggested that not only IgE but also IgG and IgA may play some etiological role in the pathogenesis of AD.
为阐明免疫球蛋白分子在特应性皮炎患者朗格汉斯细胞(LCs)中的病因学作用,我们对30例特应性皮炎(AD)患者和5名非特应性健康志愿者的表皮LCs上免疫球蛋白G1(IgG1)、IgG2、IgG3、IgG4、IgA和IgM的定位进行了免疫组织化学研究。我们还调查了这些患者表皮LCs上免疫球蛋白的受体类型(FcεRI、FcεRII、FcγRI、FcγRII和FcγRIII)。在30例AD患者中的28例观察到IgE阳性的表皮LCs,且46.7%的表皮LCs呈IgE阳性。70%的AD患者观察到IgG1和IgG2阳性的表皮LCs,分别有21.8%和28.7%的总表皮LCs呈IgG1和IgG2阳性。仅小部分AD患者存在IgG3或IgG4阳性的LCs。在8例AD患者中观察到IgA阳性的LCs;我们的研究提示,LCs上结合的IgA为分泌型IgA(S-IgA)。这些表面免疫球蛋白在AD受累皮肤的表皮LCs上的出现频率显著高于临床未受累皮肤。在AD患者或健康志愿者中未观察到IgM阳性的表皮LCs。在非特应性健康对照中,未观察到免疫球蛋白结合的LCs。在免疫球蛋白受体方面,FcεRI和FcγRII几乎在所有AD患者和所有非特应性对照的所有表皮LCs上均有表达。这些结果提示,不仅IgE,而且IgG和IgA可能在AD的发病机制中发挥某些病因学作用。